ICFG Spain acted as exclusive Financial Adviser to Fernandez y Canivell SA in its divestment of its Ceregumil brand to Spanish Pharma Uriach Group.
| Seller | Uriach Group |
| Target | Uriach Group |
| Deal Type | Mergers & Acquisitions |
| Buyer | Fernandez y Canivell SA |
| Territory | Spain |
| Transaction Description | The Buyer, Uriach, is a Spain-based family-owned pharmaceutical group that closed 2019 with revenue of EUR 228m, 16% more than the previous year, and an EBITDA of EUR 46m. The pharmaceutical company expects turnover of EUR 300m in 2022. |
| Industry Sector | Healthcare |
| ICFG Office | The Hague |
ICFG Spain acted as exclusive Financial Adviser to Fernandez y Canivell SA in its divestment of its Ceregumil brand to Spanish Pharma Uriach Group.
| Boltendahl International Partners was hired as exclusive Financial Advisor to Fernandez y Canivell SA for its divestment of its iconic “Ceregumil” healthcare brand and other assets to the pharmaceutical group Uriach in Spain. |
